tiprankstipranks
Trending News
More News >
Innovent Biologics (IVBXF)
OTHER OTC:IVBXF
US Market

Innovent Biologics (IVBXF) Balance Sheet

Compare
41 Followers

Innovent Biologics Balance Sheet

Innovent Biologics's total assets for Q2 2025 were ¥23.59B, an increase of 9.22% from the previous quarter. IVBXF total liabilities were ¥9.17B for the fiscal quarter, a 8.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
¥ 21.60B¥ 20.63B¥ 17.59B¥ 16.24B¥ 11.83B
Total Liabilities
¥ 8.48B¥ 8.10B¥ 6.86B¥ 5.91B¥ 3.06B
Total Equity Gross Minority
¥ 13.12B¥ 12.53B¥ 10.73B¥ 10.33B¥ 8.78B
Other Metrics
Currency in CNY

Innovent Biologics Debt to Assets